Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population

Teresa Casals, Javier Gimenez, Maria D. Ramos, Virginia Nunes, Xavier P. Estivill

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasian populations. The Spanish CF population is highly heterogeneous, with more than 70 different mutations causing CF. Since the CFTR gene was cloned, we have performed 81 prenatal diagnoses for 74 couples. Sixty-nine cases had a high risk (1/4) for CF and 12 presented a lower risk (1/240). Direct analysis was possible in 36 cases (44.4 per cent); it was necessary to combine mutation analysis with polymorphic markers in 24 cases (29.6 per cent); mutation analysis and microvillar enzymatic (MVE) analysis were combined in five cases (6.1 per cent); and in 16 cases (19.8 per cent), only indirect analysis was possible. Nine different mutations were detected in this series of families: 621 + 1G → T, ΔF508, 1609delCA, G542X, G551D, 1949del84, R1162X, W1282X, and N1303K. Another ten mutations were identified in these samples after prenatal diagnosis (1811 + 1.6kbA → G, 711 + 1G → T, 2869insG, G85E, 2176insC, ΔI507, 3272-26A → G, Q890X, R1066C, and 4005 + 1G → A). Our current strategy for molecular diagnosis of CF in the Spanish population is based, as a first step, on direct analysis for the two most frequent mutations (ΔF508 and G542X) and indirect analysis using the intragenic markers IVS8CA, IVS17BTA, and IVS17BCA. The second step consists of screening for the mutations already associated with the CFTR microsatellite haplotypes. The third step is a specific search for unknown mutations. While actual diagnostic methods are not automatic and robust enough for heterogeneous populations, the diagnostic strategy outlined provides rapid, accurate, and reliable prenatal diagnosis for the majority of couples.

Original languageEnglish
Pages (from-to)215-222
Number of pages8
JournalPrenatal Diagnosis
Volume16
Issue number3
DOIs
Publication statusPublished - Mar 1996
Externally publishedYes

Fingerprint

Prenatal Diagnosis
Cystic Fibrosis
Mutation
Population
Microsatellite Repeats
Haplotypes
Genes

Keywords

  • CF
  • CFTR
  • cystic fibrosis
  • heterogeneity
  • mutation analysis

ASJC Scopus subject areas

  • Genetics(clinical)
  • Obstetrics and Gynaecology

Cite this

Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population. / Casals, Teresa; Gimenez, Javier; Ramos, Maria D.; Nunes, Virginia; Estivill, Xavier P.

In: Prenatal Diagnosis, Vol. 16, No. 3, 03.1996, p. 215-222.

Research output: Contribution to journalArticle

Casals, Teresa ; Gimenez, Javier ; Ramos, Maria D. ; Nunes, Virginia ; Estivill, Xavier P. / Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population. In: Prenatal Diagnosis. 1996 ; Vol. 16, No. 3. pp. 215-222.
@article{ef8d736ccaa24de7bb12b086fedd36ae,
title = "Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population",
abstract = "Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasian populations. The Spanish CF population is highly heterogeneous, with more than 70 different mutations causing CF. Since the CFTR gene was cloned, we have performed 81 prenatal diagnoses for 74 couples. Sixty-nine cases had a high risk (1/4) for CF and 12 presented a lower risk (1/240). Direct analysis was possible in 36 cases (44.4 per cent); it was necessary to combine mutation analysis with polymorphic markers in 24 cases (29.6 per cent); mutation analysis and microvillar enzymatic (MVE) analysis were combined in five cases (6.1 per cent); and in 16 cases (19.8 per cent), only indirect analysis was possible. Nine different mutations were detected in this series of families: 621 + 1G → T, ΔF508, 1609delCA, G542X, G551D, 1949del84, R1162X, W1282X, and N1303K. Another ten mutations were identified in these samples after prenatal diagnosis (1811 + 1.6kbA → G, 711 + 1G → T, 2869insG, G85E, 2176insC, ΔI507, 3272-26A → G, Q890X, R1066C, and 4005 + 1G → A). Our current strategy for molecular diagnosis of CF in the Spanish population is based, as a first step, on direct analysis for the two most frequent mutations (ΔF508 and G542X) and indirect analysis using the intragenic markers IVS8CA, IVS17BTA, and IVS17BCA. The second step consists of screening for the mutations already associated with the CFTR microsatellite haplotypes. The third step is a specific search for unknown mutations. While actual diagnostic methods are not automatic and robust enough for heterogeneous populations, the diagnostic strategy outlined provides rapid, accurate, and reliable prenatal diagnosis for the majority of couples.",
keywords = "CF, CFTR, cystic fibrosis, heterogeneity, mutation analysis",
author = "Teresa Casals and Javier Gimenez and Ramos, {Maria D.} and Virginia Nunes and Estivill, {Xavier P.}",
year = "1996",
month = "3",
doi = "10.1002/(SICI)1097-0223(199603)16:3<215::AID-PD838>3.0.CO;2-7",
language = "English",
volume = "16",
pages = "215--222",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population

AU - Casals, Teresa

AU - Gimenez, Javier

AU - Ramos, Maria D.

AU - Nunes, Virginia

AU - Estivill, Xavier P.

PY - 1996/3

Y1 - 1996/3

N2 - Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasian populations. The Spanish CF population is highly heterogeneous, with more than 70 different mutations causing CF. Since the CFTR gene was cloned, we have performed 81 prenatal diagnoses for 74 couples. Sixty-nine cases had a high risk (1/4) for CF and 12 presented a lower risk (1/240). Direct analysis was possible in 36 cases (44.4 per cent); it was necessary to combine mutation analysis with polymorphic markers in 24 cases (29.6 per cent); mutation analysis and microvillar enzymatic (MVE) analysis were combined in five cases (6.1 per cent); and in 16 cases (19.8 per cent), only indirect analysis was possible. Nine different mutations were detected in this series of families: 621 + 1G → T, ΔF508, 1609delCA, G542X, G551D, 1949del84, R1162X, W1282X, and N1303K. Another ten mutations were identified in these samples after prenatal diagnosis (1811 + 1.6kbA → G, 711 + 1G → T, 2869insG, G85E, 2176insC, ΔI507, 3272-26A → G, Q890X, R1066C, and 4005 + 1G → A). Our current strategy for molecular diagnosis of CF in the Spanish population is based, as a first step, on direct analysis for the two most frequent mutations (ΔF508 and G542X) and indirect analysis using the intragenic markers IVS8CA, IVS17BTA, and IVS17BCA. The second step consists of screening for the mutations already associated with the CFTR microsatellite haplotypes. The third step is a specific search for unknown mutations. While actual diagnostic methods are not automatic and robust enough for heterogeneous populations, the diagnostic strategy outlined provides rapid, accurate, and reliable prenatal diagnosis for the majority of couples.

AB - Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasian populations. The Spanish CF population is highly heterogeneous, with more than 70 different mutations causing CF. Since the CFTR gene was cloned, we have performed 81 prenatal diagnoses for 74 couples. Sixty-nine cases had a high risk (1/4) for CF and 12 presented a lower risk (1/240). Direct analysis was possible in 36 cases (44.4 per cent); it was necessary to combine mutation analysis with polymorphic markers in 24 cases (29.6 per cent); mutation analysis and microvillar enzymatic (MVE) analysis were combined in five cases (6.1 per cent); and in 16 cases (19.8 per cent), only indirect analysis was possible. Nine different mutations were detected in this series of families: 621 + 1G → T, ΔF508, 1609delCA, G542X, G551D, 1949del84, R1162X, W1282X, and N1303K. Another ten mutations were identified in these samples after prenatal diagnosis (1811 + 1.6kbA → G, 711 + 1G → T, 2869insG, G85E, 2176insC, ΔI507, 3272-26A → G, Q890X, R1066C, and 4005 + 1G → A). Our current strategy for molecular diagnosis of CF in the Spanish population is based, as a first step, on direct analysis for the two most frequent mutations (ΔF508 and G542X) and indirect analysis using the intragenic markers IVS8CA, IVS17BTA, and IVS17BCA. The second step consists of screening for the mutations already associated with the CFTR microsatellite haplotypes. The third step is a specific search for unknown mutations. While actual diagnostic methods are not automatic and robust enough for heterogeneous populations, the diagnostic strategy outlined provides rapid, accurate, and reliable prenatal diagnosis for the majority of couples.

KW - CF

KW - CFTR

KW - cystic fibrosis

KW - heterogeneity

KW - mutation analysis

UR - http://www.scopus.com/inward/record.url?scp=0029872807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029872807&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0223(199603)16:3<215::AID-PD838>3.0.CO;2-7

DO - 10.1002/(SICI)1097-0223(199603)16:3<215::AID-PD838>3.0.CO;2-7

M3 - Article

VL - 16

SP - 215

EP - 222

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 3

ER -